Drug Discovery Informatics Market Size, Share, Trends And Strategies 2024-2033

"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Drug Discovery Informatics Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $6.06 billion In 2028 At A CAGR Of 12.6%.

The drug discovery informatics market size has grown rapidly in recent years. It will grow from $3.36 billion in 2023 to $3.77 billion in 2024 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to genomics and proteomics advancements, increasing complexity of drug targets, advancements in structural biology, rise in outsourcing, pharmacogenomics integration, drug repurposing strategies..

The drug discovery informatics market size is expected to see rapid growth in the next few years. It will grow to $6.06 billion in 2028 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to expansion of precision medicine, drug-drug interaction prediction, patient-derived data analysis, biosimilars development, growing number of drug candidates.. Major trends in the forecast period include ai and machine learning integration, digital twins in drug development, collaboration platforms, blockchain for data security, advancements in imaging technologies, cloud-based informatics platforms..

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=8960&type=smp

Drug Discovery Informatics Market Major Segments
The drug discovery informatics market covered in this report is segmented -

1) By Service: In-House, Outsourced
2) By Modality: Cloud-Based Systems, In-Campus
3) By Application: Data Sequencing, Molecular Docking, Identification And Validation, Target Data Analysis
4) By End-User: Pharmaceutical Companies, Contract Research Organizations, Bio-Technology Companies

Key Driver - The Impact Of Chronic Disease Prevalence On The Growth Of Informatics Solutions

The rising prevalence of various chronic diseases is expected to propel the growth of the drug discovery informatics market going forward. Chronic illnesses are described generically as disorders that persist for a year or longer and need continuing medical treatment, impede everyday activities or both. Drug discovery informatics systems aid in the advancement of chronic illness care by allowing researchers to probe more complex and transient molecular changes that underpin disease progression and drug response, resulting in multi-dimensional models of the entire hierarchical system in healthy, diseased, and treated states. For instance, according to a report published by the World Health Organization, a Switzerland-based agency of the United Nations responsible for international public health, in 2022, non-communicable diseases (NCDs) are expected to kill 41 million people, accounting for 74% of all deaths worldwide. Every year, 17 million people die from an NCD before the age of 70, with low- and middle-income nations accounting for 86% of these premature fatalities. Cardiovascular illnesses kill the most individuals each year (17.9 million), followed by cancer (9.3 million), chronic respiratory disorders (4.1 million), and diabetes (2.0 million, including kidney disease deaths caused by diabetes). Therefore, the rising prevalence of various chronic diseases is driving the growth of the drug discovery informatics market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=8960&type=smp

Prominent Trend - Certara Inc. Spearheads Technological Innovation In Drug Discovery Informatics With Simcyp Pbpk Simulator Version 20

Technological advancements have emerged as a key trend gaining popularity in the drug discovery informatics market. Major companies operating in the drug discovery informatics market are focused on developing technologically advanced solutions to sustain and strengthen their market position. For instance, in January 2021, Certara Inc., a US-based biosimulation company introduced version 20 of its Simcyp Physiologically-based Pharmacokinetic (PBPK) Simulator platform. It provides new and improved maternal health models, such as measuring medicine performance during pregnancy and lactation. The Simcyp PBPK Simulator enhances clinical trial efficiency and results by modelling and simulating pharmacokinetics (PK) and pharmacodynamics (PD) using virtual patient populations. For biological drug development, it employs the predictive pharmacokinetics of small molecules.

Drug Discovery Informatics Market Players
Major companies operating in the drug discovery informatics market report are , Certara Inc., Charles River Laboratories Inc., Infosys Ltd., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products Inc., Jubilant Biosys Ltd., Selvita S.A., PerkinElmer Inc., International Business Machines Corporation, Boehringer Ingelheim International GmbH, Oracle Corporation, Thermo Fisher Scientific Inc., Albany Molecular Research Inc., ChemAxon Ltd., Amazon Web Services Inc., Schrödinger LLC., Core Informatics LLC, Informatics Matters Ltd., Tata Consultancy Services Limited, Novo Informatics Pvt. Ltd., IO Informatics Inc., GVK Biosciences Private Limited, Dassault Systèmes SE, Recursion Pharmaceuticals Inc., Cyclica Inc., Valence Discovery Inc., Valo Health Inc., Cognizant Technology Solutions Corporation, Wipro Limited, Mindtree Limited, Persistent Systems Limited, Laurson&Turbo Infotech Private Limited, Mphasis Limited .

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/drug-discovery-informatics-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the drug discover informatics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the drug discovery informatics market during the forecast period. The regions covered in the drug discovery informatics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Drug Discovery Informatics Market Report Structure
3. Drug Discovery Informatics Market Trends And Strategies
4. Drug Discovery Informatics Market - Macro Economic Scenario
5. Drug Discovery Informatics Market Size And Growth
…..
27. Drug Discovery Informatics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.